Literature DB >> 27181782

Phospholipase A2 receptor staining is absent in many kidney biopsies with early-stage membranous glomerulonephritis.

Margaret S Ryan1, Anjali A Satoskar1, Gyongyi M Nadasdy1, Sergey V Brodsky1, Jessica A Hemminger1, Tibor Nadasdy2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27181782     DOI： 10.1016/j.kint.2015.12.057

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  7 in total

1.  M-type phospholipase A2 receptor (PLA2R) glomerular staining in pediatric idiopathic membranous nephropathy.

Authors:  Shoichiro Kanda; Shigeru Horita; Takeshi Yanagihara; Akira Shimizu; Motoshi Hattori
Journal:  Pediatr Nephrol       Date:  2016-12-05       Impact factor: 3.714

Review 2.  Primary Membranous Nephropathy.

Authors:  William G Couser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

Review 3.  The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice.

Authors:  Iwona Smarz-Widelska; Dariusz Chojęta; Małgorzata M Kozioł
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

Review 4.  PLA2R and THSD7A: Disparate Paths to the Same Disease?

Authors:  Laurence H Beck
Journal:  J Am Soc Nephrol       Date:  2017-07-03       Impact factor: 10.121

Review 5.  Segmental membranous nephropathy.

Authors:  Hae Yoon Grace Choung; Bruce Goldman
Journal:  Clin Exp Nephrol       Date:  2021-03-23       Impact factor: 2.801

Review 6.  Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy.

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Front Immunol       Date:  2021-03-22       Impact factor: 7.561

7.  Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels.

Authors:  Yuemeng Sun; Ping Lan; Jie Feng; Zhigang Wang; Chao Liu; Liyi Xie; Xiaoyang Yu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.